Andrew Hetherington
Profile
Andrew Hetherington held several senior positions in the pharmaceutical industry, including Manufacturing Director & Senior Manager-Production at Bayer HealthCare, Head-Immuno Manufacturing at Novartis, and Production Manager-Solid Dose Manufacturing at Glaxo Wellcome.
He also served as Senior Vice President-Technical Operations at Catalyst Biosciences from 2017 to 2020.
Hetherington earned an undergraduate degree from Monash University and an MBA from The Wharton School of the University of Pennsylvania.
Former positions of Andrew Hetherington
Companies | Position | End |
---|---|---|
CATALYST BIOSCIENCES | Chief Tech/Sci/R&D Officer | 2020-11-30 |
Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Part of Bayer AG, Bayer HealthCare is a private company that provides medical care and animal health care services. The company is based in Tarrytown, NY. | Corporate Officer/Principal | - |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Corporate Officer/Principal | - |
Training of Andrew Hetherington
Monash University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Linked companies
Private companies | 4 |
---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
Glaxo Wellcome, Inc. | Health Technology |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Part of Bayer AG, Bayer HealthCare is a private company that provides medical care and animal health care services. The company is based in Tarrytown, NY. | Health Services |
Catalyst Biosciences, Inc.
Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Andrew Hetherington